• WTAP-Driven Glutaminase Splicing Suppresses Ferroptosis in H

  2026-05-13

  This study uncovers how EGFR-AKT signaling in hepatocellular carcinoma (HCC) promotes WTAP-mediated alternative splicing of glutaminase, resulting in a metabolic adaptation that suppresses ferroptosis and drives tumor growth. The findings provide mechanistic insight into m6A-dependent regulation of glutaminolysis and suggest new therapeutic avenues targeting metabolic reprogramming in HCC.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-05-13

  This study presents an M2 microglia-targeted lipid nanoparticle system for delivering IL-10 mRNA to ischemic brain regions, significantly restoring blood-brain barrier integrity and reducing neuroinflammation after stroke. The findings highlight a novel, feedback-augmented strategy for extending the therapeutic window in mRNA-based neuroprotection.

• HyperScript III RT SuperMix: Precision qPCR for CRC Biomarke

  2026-05-12

  HyperScript III RT SuperMix delivers high-fidelity cDNA synthesis for robust gene expression analysis by qPCR, even from challenging low-concentration or high-GC content RNA samples. Its integrated gDNA wiper simplifies workflows and ensures contamination-free results, directly supporting translational oncology and precision biomarker discovery.

• Affordable GRO-seq Protocol for Nascent RNA Profiling in Whe

  2026-05-12

  Chen et al. present a cost-efficient Global Run-On sequencing (GRO-seq) protocol for profiling nascent RNAs in bread wheat by introducing an rRNA depletion step after nuclear RNA isolation. This innovation significantly enhances data yield and lowers sequencing costs, increasing the applicability of GRO-seq to complex plant genomes.

• Decoding SOD Activity: Precision Redox Analysis with K2035 K

  2026-05-11

  Explore the science behind the Superoxide Dismutase Activity Assay Kit and its advantages for advanced redox biology. This article unpacks mechanistic detail, critical assay choices, and real-world applications for researchers measuring SOD activity with precision.

• Superoxide Dismutase Activity Assay Kit: Precision, Pitfalls

  2026-05-11

  Explore advanced strategies for SOD activity quantification using the Superoxide Dismutase Activity Assay Kit. Discover unique protocol insights, pitfalls from recent literature, and how to achieve unmatched oxidative stress assay reliability.

• Hormonal Control of Fruit Abscission in Actinidia arguta Rev

  2026-05-10

  This study dissects the molecular mechanisms driving physiological fruit abscission in Actinidia arguta by leveraging comparative transcriptomics and transient genetic transformation. The findings clarify hormone signaling networks and cell wall modifications underlying cultivar-specific abscission, with implications for targeted breeding and crop yield optimization.

• β-Amanitin: Molecular Tool for Decoding Eukaryotic Transcrip

  2026-05-09

  Discover the molecular underpinnings of β-Amanitin in RNA polymerase II inhibition, its value for transcriptional regulation research, and how new detection innovations are shaping assay reliability. This article uniquely explores the integration of β-Amanitin's biochemical properties with advanced practical guidance for experimental design.

• HyperScript RT SuperMix for qPCR: Precision cDNA Synthesis

  2026-05-08

  HyperScript RT SuperMix for qPCR enables high-fidelity cDNA synthesis, even from low concentration or structurally complex RNA. Its engineered M-MLV reverse transcriptase delivers robust performance for gene expression analysis. This article details the product's mechanism, evidence, and integration into qRT-PCR workflows.

• Resibufogenin Inhibits NLRP3 Inflammasome to Mitigate Athero

  2026-05-08

  This study demonstrates that resibufogenin (RBG) offers significant protection against atherosclerosis in ApoE-/- mice by blocking the assembly of the NLRP3 inflammasome. The findings highlight RBG’s mechanistic impact on macrophage polarization and inflammation, providing a promising avenue for future cardiovascular disease interventions.

• Reliable cDNA Synthesis with HyperScript™ RT SuperMix for qP

  2026-05-07

  This article delivers scenario-driven, evidence-based guidance for biomedical researchers seeking reproducible gene expression analysis using HyperScript™ RT SuperMix for qPCR (SKU K1074). Drawing on real-world laboratory challenges, we demonstrate how this optimized reverse transcription kit ensures sensitive and reliable cDNA synthesis, especially for low-abundance or structurally complex RNA templates.

• Doxorubicin (SKU A3966): Reliable Cytotoxicity in Cancer Ass

  2026-05-07

  This article guides biomedical researchers through common experimental hurdles in cell viability and cytotoxicity assays, using Doxorubicin (SKU A3966) as a validated, reproducible solution. Evidence-backed Q&A scenarios clarify protocol parameters, product reliability, and practical optimization to ensure robust and interpretable results in cancer research workflows.

• Acifran in Lipid Metabolism Research: Workflows & Troublesho

  2026-05-06

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) provides unparalleled selectivity for dissecting lipid signaling via HM74A/GPR109A and GPR109B. This guide delivers actionable experimental protocols, troubleshooting strategies, and insights from recent cryo-EM breakthroughs, making Acifran the trusted tool for next-generation lipid metabolism studies.

• Precision Reverse Transcription: Advancing CRC Biomarker Res

  2026-05-06

  This thought-leadership article explores the mechanistic basis and translational impact of using HyperScript™ RT SuperMix for qPCR in colorectal cancer biomarker discovery. By synthesizing insights from foundational biomarker research and advanced reverse transcription chemistry, it offers strategic guidance for translational researchers aiming to achieve reproducible, clinically meaningful gene expression analysis—especially when working with low-concentration or structurally complex RNA.

• RWJ 67657: Redefining p38α/β MAPK Inhibition for Translation

  2026-05-05

  This article explores how RWJ 67657 (JNJ-3026582) advances p38α/β MAP kinase inhibition, offering mechanistic clarity and strategic guidance for translational researchers in inflammatory disease. Integrating new evidence on dual-action kinase inhibition, the piece discusses the implications for reproducible cytokine modulation, experimental design, and future therapeutic targeting, while highlighting APExBIO’s role in providing validated research reagents.

525 records 1/35 page Next 12345 下5页 Last page